• Home
  • MyECTS
  • Become a member
  • Contact us

Ectsoc

Ecstoc.org

MENUMENU
  • About
    • Mission & Vision
    • Governance & Transparency
    • Board of Directors
    • Annual General Meeting
    • Committees and Action Groups
      • Executive Committee
      • Communications Committee
      • Community Engagement Committee
      • ECTS Academy
      • Education Committee
      • Clinical Science Committee
      • Research Committee
      • Scientific Programme Committee 2025
    • ECTS Team
    • Membership
      • Individual Membership
      • Corporate Supporters
      • Join us
      • Affiliated Societies
  • ECTS 2025
  • Events
    • Upcoming Congresses
    • Past Congress
    • ECTS Academy Charity Event
    • ICCBH
    • Events
  • Grants & Awards
  • Education
    • PhD Training Course
    • Clinical Training Course in Metabolic Bone Diseases
    • Rare Bone Diseases Webinars
    • Education Resource Center
    • Bone Muscle & Beyond Webinars
    • ECTS-Mellanby Training Course
    • Calendar ECTS Educational Events
  • ECTS Academy
    • About the ECTS Academy
    • ECTS Academy – Members
    • Call for Applications - Basic Scientists
    • Call for Applications - Clinicians
    • ECTS Academy Activities
      • NI Conference Program
      • ECTS Academy Webinar Series
      • ECTS Academy Mentoring Options
      • ECTS Academy Charity Run
    • Visit the ECTS Academy website
  • News
    • ECTS Newsletter
    • News
    • Press Release
    • Image Library
    • Video Library
    • Job Advertisements
You are here: Home / Education / E-learning / ECTS Webinar Series Bone, Muscle & Beyond / Osteosarcoma

Osteosarcoma

Osteosarcoma

Organised with the support of the Cancer and Bone Society (CABS)

Live Webinar: 9 June 2020, 9am CEST 

Register

Date & Time: 9 June 2020, 9am CEST

Featuring David Thomas, Head of the Cancer Theme, Garvan Institute of Medical Research

Moderated by Hanna Taipaleenmäki, ECTS Academy Member.

Costs: Live webinar is free for ECTS members and non-members, but a registration is required.

Recordings are accessible to ECTS members only.

Format:

  • 5 min welcome & introductions
  • 35 min presentation
  • 20 min Q&A

Learning Objectives:

  • Osteosarcoma and immunotherapy
  • Using human and mouse genetics of sarcomas
  • Non-canonical and druggable immune pathways in osteosarcoma
  • Paths to clinical trials in rare diseases

Featuring David Thomas

Prof Thomas is Head of the Cancer Theme at the Garvan Institute of Medical Research, and Director of The Kinghorn Cancer Centre.  He is a NHMRC Principal Research Fellow and medical oncologist whose focus is on the application of genomic technologies to the understanding and management of cancer.  Prof Thomas founded the Australasian Sarcoma Study Group, a national research organisation, and established Australia’s leading adolescent and young adult cancer unit at the Peter MacCallum Cancer Centre.  
 
Dr Thomas leads the International Sarcoma Kindred Study, now recruiting from 23 centres in 7 countries, and led the first international study of denosumab in Giant Cell Tumor of bone, leading to FDA and TGA approval.  He has over 150 research publications, including lead or senior author papers in Cancer Cell, Molecular Cell, Journal of Clinical Investigation, Lancet Oncology, JAMA Oncology, and Journal of Clinical Oncology. Since moving to NSW, he has established the Australian Genomic Cancer Medicine Centre, a national precision medicine program for patients with rare and early onset cancers.  In 2018, he was President of the Connective Tissue Oncology Society, the peak international body in his field. He has created a national program in genomics medicine – the Australian Genomic Cancer Medicine Program – unifying for the first time the major cancer centres in every state and territory, as well as three of Australia’s leading research organizations (WEHI, Garvan, NHMRC CTC).
Copyright 2016 ECTS - Disclaimer - Cookies Policy - Privacy Policy - Privacy Centre - Terms of use - Contact us